Alongside our recently awarded ISO13485 certification for the contract development and manufacturing of electrochemical biosensors and IVDs, ZP is delighted to announce an expansion into a new 4000 square meter facility.
ZP will retain it's existing Norwegian facility assets, and so the access to this dedicated manufacturing building will allow us to house the considerable CAPEX investment in manufacturing technologies for electrochemical IVDs and biosensors that are being made in 2021.